Overview

Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to determine whether this treatment may be useful for reducing cannabis consumption; reducing symptoms of bipolar mania; and weight mitigation therapy for individuals on psychopharmacotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Quetiapine Fumarate
Topiramate